Cell invasion is affected by differential expression of the urokinase plasminogen activated/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients

被引:46
作者
Fibbi, G
Barletta, E
Dini, G
Del Rosso, A
Pucci, M
Cerletti, M
Del Rosso, M
机构
[1] Univ Florence, Dept Expt Pathol & Oncol, I-50134 Florence, Italy
[2] Univ Florence, Dept Internal Med 4, I-50134 Florence, Italy
[3] Ist Nazl Neurol Carlo Besta, Milan, Italy
关键词
D O I
10.1038/labinvest.3780209
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to evaluate the differential expression and the function in cell movement and proliferation of the urokinase plasminogen activator (u-PA) system in muscle satellite cells (MSC) of normal individuals and patients with Duchenne muscular dystrophy (DMD). By immunoenzymatic, zymographic, and radioligand binding methods and by quantitative polymerase chain reaction of the specific mRNA we have shown that both normal and DMD MSC produce u-PA and the plasminogen activator inhibitor-1 and express u-PA receptors (Le-PAR). During the proliferation phase of their growth-differentiation program, MSC from DMD patients show more u-PAR than their normal counterpart, produce more plasminogen activator inhibitor-1, and release low amounts of u-PA into the culture medium. By Boyden chamber Matrigel invasion assays we have shown that normal MSC are more prone than DMD cells to spontaneous invasion but, when subjected to a chemotactic gradient of u-PA, DMD MSC sense the ligand much better and to a greater extent than normal MSG. u-PA also stimulates proliferation of MSG, but no difference is observable between normal and DMD patients. Antagonization of u-PA/u-PAR interaction with specific anti-u-PA and anti-u-PAR monoclonal antibodies and with antisense oligonucleotides inhibiting u-PAR expression indicates that u-PA/u-PAR interaction is required in spontaneous and u-PA-induced invasion, as well as in u-PA-induced proliferation.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 38 条
[21]   CELL TRANSPLANTATION AND GENE-THERAPY IN MUSCULAR-DYSTROPHY [J].
MORGAN, JE ;
PARTRIDGE, TA .
BIOESSAYS, 1992, 14 (09) :641-645
[22]   SATELLITE CELLS AS SOURCE OF NUCLEI IN MUSCLES OF GROWING RATS [J].
MOSS, FP ;
LEBLOND, CP .
ANATOMICAL RECORD, 1971, 170 (04) :421-&
[23]  
MunozCanoves P, 1997, THROMB HAEMOSTASIS, V77, P526
[24]  
NAFFAKH N, 1993, NEUROMUSCULAR DISORD, V3, P413, DOI 10.1016/0960-8966(93)90087-Z
[25]   CONVERSION OF MDX MYOFIBERS FROM DYSTROPHIN-NEGATIVE TO DYSTROPHIN-POSITIVE BY INJECTION OF NORMAL MYOBLASTS [J].
PARTRIDGE, TA ;
MORGAN, JE ;
COULTON, GR ;
HOFFMAN, EP ;
KUNKEL, LM .
NATURE, 1989, 337 (6203) :176-179
[26]   THE PLASMINOGEN SYSTEM AND CELL-SURFACES - EVIDENCE FOR PLASMINOGEN AND UROKINASE RECEPTORS ON THE SAME CELL TYPE [J].
PLOW, EF ;
FREANEY, DE ;
PLESCIA, J ;
MILES, LA .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2411-2420
[27]  
QUATTRONE A, 1995, CANCER RES, V55, P90
[28]   MODULATION OF ACTIVITIES AND RNA LEVEL OF THE COMPONENTS OF THE PLASMINOGEN ACTIVATION SYSTEM DURING FUSION OF HUMAN MYOGENIC SATELLITE CELLS-INVITRO [J].
QUAX, PHA ;
FRISDAL, E ;
PEDERSEN, N ;
BONAVAUD, S ;
THIBERT, P ;
MARTELLY, I ;
VERHEIJEN, JH ;
BLASI, F ;
BARLOVATZMEIMON, G .
DEVELOPMENTAL BIOLOGY, 1992, 151 (01) :166-175
[29]   CLONING AND EXPRESSION OF THE RECEPTOR FOR HUMAN UROKINASE PLASMINOGEN-ACTIVATOR, A CENTRAL MOLECULE IN CELL-SURFACE, PLASMIN DEPENDENT PROTEOLYSIS [J].
ROLDAN, AL ;
CUBELLIS, MV ;
MASUCCI, MT ;
BEHRENDT, N ;
LUND, LR ;
DANO, K ;
APPELLA, E ;
BLASI, F .
EMBO JOURNAL, 1990, 9 (02) :467-474
[30]  
STRITTMATTER WA, 1982, MUSCLE DEV MOL CELLU, P317